Science
Mechanism of Action
This ingredient operates via a dual-action pathway: first, it serves as a Nitric Oxide donor, releasing NO under physiological conditions to stimulate microcirculation, accelerate tissue repair, and modulate inflammatory responses. Second, its inherent positive charge (cationic) allows it to electrostatically bind to the skin's surface, creating a protective film that prevents transepidermal water loss and physically disrupts negatively charged bacterial membranes.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Demonstrated efficacy as a Nitric Oxide donor for counteracting age-related NO deficiency and enhancing barrier integrity (Patent WO/2020/197385).
- 02 Identified as an optimal regenerative and antimicrobial agent in stable dermatological emulsions at concentrations between 0.5% and 2% (WIPO NL2022788B1).
Transparency
Dusting Analysis
Because it is a complex salt often marketed for 'Nitric Oxide delivery,' it is frequently included at trace amounts (under 0.1%) for label claims. To achieve measurable antimicrobial protection and film-forming benefits, a minimum threshold of 0.5% is required.
The Formula
Formulation
Stability
Chitosan Nitrate is highly water-soluble compared to standard Chitosan, but it is pH-sensitive; it remains stable in slightly acidic environments but may precipitate if the formulation exceeds pH 6.5.
Synergies
- Non-ionic humectants
- Nitric oxide precursors
- Lactic acid
Conflicts
- Anionic surfactants (SLS)
- Carbomers
- Xanthan Gum
- Anionic pigments
- Divalent metal ions
Safety
Safety Profile
While specifically the nitrate salt is not extensively reviewed by the CIR, Chitosan itself is FDA-cleared for medical wound care and is recognized for its biocompatibility and low toxicological profile.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional multi-functional polymer for high-precision barrier repair and healthy aging, provided the formulation avoids anionic conflicts.
Related
Similar Ingredients
Finding similar ingredients…